Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bp Consulting, Inc
• Treatments: Lubricant Eye Drops

Criteria

Inclusion Criteria:

• Patient reported dry eye symptoms (episodic, annoying, activity limiting), SES OD.

• Physician assessment of mild-moderate dry eye

• Patient willing to instill drops QID and complete entire length of protocol.

• TBUT < 10 seconds

• BCVA of 20/30 or better

Exclusion Criteria:

• Current topical cyclosporine use (Restasis)

• Current Systane use

• Refractive surgery within the last 6 months

• Oral or topical corticosteroid use

• Severe dry eye patients by physician assessment

• current active Blepharitis

• Oral Doxycyclines use

• Oral Antihistamine use